Nadler Leads House's End Prescription Drug Ads Now Act
Rep. Jerry Nadler, D-N.Y., led filing Thursday of a House companion (HR-4605) of the Senate's End Prescription Drug Ads Now Act (S-2068). HR-4605/S-2068 would ban “direct-to-consumer” broadcast and other forms of advertising for all prescription drugs. Senate Health, Education, Labor and Pensions Committee ranking member Bernie Sanders, I-Vt., and Sen. Angus King, I-Maine, filed S-2068 in June.
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
“Pharmaceutical companies spend billions of dollars on ads that drive up the cost of their already expensive prescription drugs,” Nadler said. HR-4605 “will lower pharmaceutical drug prices for Americans by putting a stop to these wasteful ads that are banned in all but one other country in the world. It will also protect our most vulnerable by ensuring they get the best information about medical treatments from their doctors and providers, not from misleading prescription drug advertisements.” Reps. Maxine Dexter, D-Ore., and Ilhan Omar, D-Minn., signed on as co-sponsors.
“Big Pharma spending billions on direct-to-consumer ads makes needed medications more expensive and erodes trust in the healthcare system,” Dexter said. “These ads exploit fear and make our healthcare system even more profit-driven,” Omar said. “Banning them is a necessary step toward putting people before profit and restoring trust in medical care that centers patients, not corporations.”